4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0000950170-25-002814
General Counsel sold 471 shares at $5.60 ($2,638)
- General Counsel acquired 1,320 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Winslow Garrett General Counsel | 2025-01-03 | Option exercise | +1,320 | 1,480 | D | ||
| Winslow Garrett General Counsel | 2025-01-03 | Sale | −471 | $5.60 | $2,638 | 1,009 | D |
| Derivatives | |||||||
| Winslow Garrett General Counsel | 2025-01-03 | Option exercise · Restricted Stock Units | −1,320 | 2,680 | D | ||
| Winslow Garrett General Counsel | 2025-01-03 | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | D | ||
| Open-market sales · 471 sh · avg $5.60 · $2,638 | |||||||
Loading xslF345X05/ownership.xml…